4 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Tarsa Therapeutics, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis Oral calcitonin at dinnertime, Oral placebo at dinnertime, Oral calcitonin at bedtime - Osteopenia | Phase 2 | Completed | Tarsa Therapeutics, Inc. | 129 | 2011-01-01 | 2014-09-12 |
| A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women Oral Calcitonin Tablets, Intranasal Calcitonin, Placebo tablets and placebo intranasal spray - Osteoporosis, Postmenopausal | Phase 3 | Completed | Tarsa Therapeutics, Inc. | 565 | 2009-06-01 | 2013-11-19 |
| A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women Oral rsCT tablet, Oral Placebo Tablet, Fortical (rsCT) nasal spray - Phase 1 Pharmacodynamic Study | Phase 2 | Completed | Tarsa Therapeutics, Inc. | 12 | 2008-12-01 | 2014-06-09 |
| A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women Recombinant Salmon Calcitonin (rsCT), Oral Tablet, Nasal Spray - Osteoporosis | Phase 2 | Completed | Tarsa Therapeutics, Inc. | 24 | 2008-02-01 | 2012-02-01 |
Osteoporosis (2) · Osteoporosis, Postmenopausal (2) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Musculoskeletal Diseases (1)
salmon calcitonin (3) · Nasal Sprays (2) · Calcitonin (1) · Tablets (1)
United States (4) · Bulgaria (1) · Hungary (1) · Poland (1) · South Africa (1) · United Kingdom (1)
Thomas Legg, D.O. (2) · David Krause, M.D. (1) · David S. Krause, MD (1)
2008 (1)